AU Patent

AU2019408382B2 — Peptides for treatment and prevention of diabetes and associated disorders

Assigned to Institut National de la Sante et de la Recherche Medicale INSERM · Expires 2024-09-19 · 2y expired

What this patent protects

The present invention relates to peptides for the treatment of diabetes and associated disorders.

USPTO Abstract

The present invention relates to peptides for the treatment of diabetes and associated disorders.

Drugs covered by this patent

Subutex (BUPRENORPHINE) · Purdue Pharma Lp

Patent Metadata

Patent number: AU2019408382B2
Jurisdiction: AU
Classification: —
Expires: 2024-09-19
Drug substance claim: No
Drug product claim: No
Assignee: Institut National de la Sante et de la Recherche Medicale INSERM
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.